Imunon, Inc. IMNN
1.41
0.06
4.44%
as of 25 Sep
- Market cap
- $7.3M
- P/E
- 0.0×
Follow IMNN
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(233.50%) | (256.41%) | (768.26%) | (641.02%) | |
| (122.58%) | (131.74%) | (196.78%) | (123.93%) | ||
ROIC |
0.00% | 0.00% | 0.00% | (324.37%) | |
Return on Tangible Assets |
(391.39%) | (218.63%) | (502.35%) | (337.03%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(5.08) | (6.68) | (2.99) | (2.90) | |
Free Cash Flow |
(14.95) | (14.18) | (15.03) | (15.20) | |
Capital Expenditures |
(0.29) | (0.28) | — | (0.09) | |
| Other line items | |||||
Cash ROIC |
(157.09%) | (87.71%) | (184.39%) | (91.09%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.02 | 0.96 | 1.03 | 1.03 | |
Depreciation/Fixed assets |
1.16 | 1.32 | 1.45 | 1.56 | |
Capex/Depreciation |
(0.42) | (0.40) | 0.00 | (0.13) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(4.98) | (6.54) | (2.99) | (2.89) | |
Capex per Share |
(0.10) | (0.13) | 0.00 | (0.02) | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates